{
    "xml": "<topic id=\"PHP8693\" outputclass=\"drug\" rev=\"1.11\" type=\"drug\" namespace=\"/drugs/levobupivacaine\" basename=\"levobupivacaine\" title=\"LEVOBUPIVACAINE\">\n<title>LEVOBUPIVACAINE</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_906\" namespace=\"/interactions/list-of-drug-interactions/anaesthetics-local/levobupivacaine\">Levobupivacaine</xref>\n</p>\n<data name=\"vtmid\">116103003</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_876717894\" title=\"Anaesthetics (local)\">Anaesthetics (local)</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">   </data>\n</data>\r\n</body>\n<topic id=\"PHP63055\" outputclass=\"indicationsAndDose\" rev=\"1.33\" parent=\"/drugs/levobupivacaine\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Acute postoperative pain</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By continuous epidural infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>12.5&#8211;18.75&#8239;mg/hour, dose administered using a 1.25&#8239;mg/mL (0.125%) or 2.5&#8239;mg/mL (0.25%) solution; maximum 400&#8239;mg per day.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Acute labour pain</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">Initially by lumbar epidural</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>15&#8211;25&#8239;mg every 15&#8239;minutes as required, dose administered using a 2.5&#8239;mg/mL (0.25%) solution, alternatively (by continuous epidural infusion) 5&#8211;12.5&#8239;mg/hour, dose administered using a 1.25&#8239;mg/mL (0.125%) solution.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Surgical anaesthesia, peripheral nerve block</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By regional administration</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>2.5&#8211;150&#8239;mg, dose administered using a 2.5&#8239;mg/mL (0.25%) or 5&#8239;mg/mL (0.5%) solution.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Surgical anaesthesia, peribulbular nerve block</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By regional administration</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>37.5&#8211;112.5&#8239;mg, dose administered using a 7.5&#8239;mg/mL (0.75%) solution.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Surgical anaesthesia for caesarean section</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By lumbar epidural</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>75&#8211;150&#8239;mg, to be given over 15 &#8211;20 minutes, dose administered using a 5&#8239;mg/mL (0.5%) solution.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Surgical anaesthesia</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By lumbar epidural</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>50&#8211;150&#8239;mg, to be given over 5 minutes, dose administered using a 5&#8239;mg/mL (0.5%) or 7.5&#8239;mg/mL (0.75%) solution.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">By intrathecal injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>15&#8239;mg, dose administered using a 5&#8239;mg/mL (0.5%) solution.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">By local infiltration</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>2.5&#8211;150&#8239;mg, dose administered using a 2.5&#8239;mg/mL (0.25%) solution.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"extremesOfBodyWeight\">\n<title>Doses at extremes of body-weight</title>\n<p>To avoid excessive dosage in obese patients, dose may need to be calculated on the basis of ideal body- weight.</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP63126\" outputclass=\"importantSafetyInformation\" rev=\"1.14\" parent=\"/drugs/levobupivacaine\">\n<title>Important safety information</title>\n<body>\n<section>\n<sectiondiv>\n<p>The licensed doses stated may not be appropriate in some settings and expert advice should be sought.</p>\n<p>Should only be administered by, or under the direct supervision of, personnel experienced in their use, with adequate training in anaesthesia and airway management, and should not be administered parenterally unless adequate resuscitation equipment is available.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP63131\" outputclass=\"contraindications\" rev=\"1.15\" parent=\"/drugs/levobupivacaine\">\n<title>Contra-indications</title>\n<body>\n<section outputclass=\"contraindications\">\n<p>\n<ph outputclass=\"contraindication\">Application to the middle ear (can cause ototoxicity)</ph>; <ph outputclass=\"contraindication\">avoid injection into infected tissues</ph>; <ph outputclass=\"contraindication\">avoid injection into inflamed tissues</ph>; <ph outputclass=\"contraindication\">complete heart block</ph>; <ph outputclass=\"contraindication\">preparations containing preservatives should not be used for caudal, epidural, or spinal block, or for intravenous regional anaesthesia (Bier&#8217;s block)</ph>; <ph outputclass=\"contraindication\">should not be applied to damaged skin</ph>\n</p>\n</section>\n<section outputclass=\"importantAdvice\">\n<title>Contra-indications, further information</title>\n<sectiondiv>\n<p outputclass=\"title\">Injection site</p>\n<p>Local anaesthetics should not be injected into inflamed or infected tissues nor should they be applied to damaged skin. Increased absorption into the blood increases the possibility of systemic side-effects, and the local anaesthetic effect may also be reduced by altered local pH.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP63161\" outputclass=\"cautions\" rev=\"1.17\" parent=\"/drugs/levobupivacaine\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Cardiovascular disease</ph>; <ph outputclass=\"caution\">debilitated patients (consider dose reduction)</ph>; <ph outputclass=\"caution\">elderly (consider dose reduction)</ph>; <ph outputclass=\"caution\">epilepsy</ph>; <ph outputclass=\"caution\">hypovolaemia</ph>; <ph outputclass=\"caution\">impaired cardiac conduction</ph>; <ph outputclass=\"caution\">impaired respiratory function</ph>; <ph outputclass=\"caution\">myasthenia gravis</ph>; <ph outputclass=\"caution\">shock</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP63041\" outputclass=\"interactions\" rev=\"1.7\" parent=\"/drugs/levobupivacaine\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (levobupivacaine).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP62969\" outputclass=\"sideEffects\" rev=\"1.19\" parent=\"/drugs/levobupivacaine\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Anaemia</ph>; <ph outputclass=\"sideEffect\">arrhythmias</ph>; <ph outputclass=\"sideEffect\">blurred vision</ph>; <ph outputclass=\"sideEffect\">cardiac arrest</ph>; <ph outputclass=\"sideEffect\">convulsions</ph>; <ph outputclass=\"sideEffect\">dizziness</ph>; <ph outputclass=\"sideEffect\">drowsiness</ph>; <ph outputclass=\"sideEffect\">feeling of inebriation</ph>; <ph outputclass=\"sideEffect\">headache</ph>; <ph outputclass=\"sideEffect\">lightheadedness</ph>; <ph outputclass=\"sideEffect\">muscle twitching</ph>; <ph outputclass=\"sideEffect\">myocardial depression (resulting in hypotension and bradycardia)</ph>; <ph outputclass=\"sideEffect\">nausea</ph>; <ph outputclass=\"sideEffect\">numbness of the tongue and perioral region</ph>; <ph outputclass=\"sideEffect\">paraesthesia (including sensations of hot and cold)</ph>; <ph outputclass=\"sideEffect\">peripheral vasodilatation (resulting in hypotension and bradycardia)</ph>; <ph outputclass=\"sideEffect\">pyrexia</ph>; <ph outputclass=\"sideEffect\">restlessness</ph>; <ph outputclass=\"sideEffect\">sweating</ph>; <ph outputclass=\"sideEffect\">tinnitus</ph>; <ph outputclass=\"sideEffect\">transient excitation (followed by depression with drowsiness, respiratory failure, unconsciousness, and coma)</ph>; <ph outputclass=\"sideEffect\">tremors</ph>; <ph outputclass=\"sideEffect\">vomiting</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"sideEffectsAdvice\">\n<title>Side-effects, further information</title>\n<sectiondiv>\n<p outputclass=\"title\">Toxic effects</p>\n<p>Toxic effects after administration of local anaesthetics are a result of excessively high plasma concentrations; severe toxicity usually results from inadvertent intravascular injection or too rapid injection.</p>\n<p>Following most regional anaesthetic procedures, maximum arterial plasma concentration of anaesthetic develops within about 10 to 25 minutes, so careful surveillance for toxic effects is necessary during the first 30 minutes after injection.</p>\n<p>The systemic toxicity of local anaesthetics mainly involves the central nervous and cardiovascular systems.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP63178\" outputclass=\"allergyAndCrossSensitivity\" rev=\"1.10\" parent=\"/drugs/levobupivacaine\">\n<title>Allergy and cross-sensitivity</title>\n<body>\n<section outputclass=\"allergyAndCrossSensitivityCrossSensitivity\">\n<sectiondiv>\n<p outputclass=\"title\">Hypersensitivity and cross-sensitivity</p>\n<p>Hypersensitivity reactions occur mainly with the ester-type local anaesthetics, such as tetracaine and chloroprocaine; reactions are less frequent with the amide types, such as articaine, bupivacaine, levobupivacaine, lidocaine, mepivacaine, prilocaine, and ropivacaine. Cross-sensitivity reactions may be avoided by using the alternative chemical type.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP63027\" outputclass=\"pregnancy\" parent=\"/drugs/levobupivacaine\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Large doses during delivery can cause neonatal respiratory depression, hypotonia, and bradycardia after epidural block.</p>\n<p>Avoid if possible in the first trimester&#8212;toxicity in <i>animal</i> studies.</p>\n<p>May cause fetal distress syndrome.</p>\n<p>Do not use for paracervical block in obstetrics.</p>\n<p>Do not use 7.5&#8239;mg/mL strength in obstetrics.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP63171\" outputclass=\"breastFeeding\" parent=\"/drugs/levobupivacaine\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Amount too small to be harmful.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP63094\" outputclass=\"hepaticImpairment\" parent=\"/drugs/levobupivacaine\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Use with caution.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP63186\" outputclass=\"directionsForAdministration\" rev=\"1.8\" parent=\"/drugs/levobupivacaine\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p>For 1.25&#8239;mg/mL concentration dilute standard solutions with sodium chloride 0.9%.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP62205\" outputclass=\"prescribingAndDispensingInformation\" rev=\"1.15\" parent=\"/drugs/levobupivacaine\">\n<title>Prescribing and dispensing information</title>\n<body>\n<section>\n<sectiondiv>\n<p>Levobupivacaine is an isomer of bupivacaine.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP8693-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/levobupivacaine\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75739\" title=\"Solution for injection\" namespace=\"/drugs/levobupivacaine/solution-for-injection\">Solution for injection</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75750\" title=\"Infusion\" namespace=\"/drugs/levobupivacaine/infusion\">Infusion</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78353\" namespace=\"/treatment-summaries/local-anaesthesia\" title=\"Local anaesthesia\" count=\"1\" rel=\"backlink\">Local anaesthesia</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_906\" namespace=\"/interactions/list-of-drug-interactions/anaesthetics-local/levobupivacaine\" title=\"Levobupivacaine\" count=\"1\" rel=\"link\">Levobupivacaine</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75739\" namespace=\"/drugs/levobupivacaine/solution-for-injection\" title=\"Solution for injection\" count=\"1\" rel=\"link\">Solution for injection</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75750\" namespace=\"/drugs/levobupivacaine/infusion\" title=\"Infusion\" count=\"1\" rel=\"link\">Infusion</xref>\n</links>\n</topic>",
    "id": "PHP8693",
    "outputclass": "drug",
    "rev": "1.11",
    "type": "drug",
    "namespace": "/drugs/levobupivacaine",
    "basename": "levobupivacaine",
    "title": "LEVOBUPIVACAINE",
    "interactants": [
        {
            "id": "bnf_int_906",
            "label": "Levobupivacaine"
        }
    ],
    "vtmid": "116103003",
    "drugClassification": [
        "Anaesthetics (local)"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Acute postoperative pain",
                        "html": "Acute postoperative pain"
                    }
                ],
                "specificity": {
                    "routes": [
                        "continuous epidural infusion"
                    ],
                    "textContent": "By continuous epidural infusion",
                    "html": "By continuous epidural infusion"
                },
                "adult": [
                    {
                        "textContent": "12.5&#8211;18.75 mg/hour, dose administered using a 1.25 mg/mL (0.125%) or 2.5 mg/mL (0.25%) solution; maximum 400 mg per day.",
                        "html": "<p>12.5&#8211;18.75&#8239;mg/hour, dose administered using a 1.25&#8239;mg/mL (0.125%) or 2.5&#8239;mg/mL (0.25%) solution; maximum 400&#8239;mg per day.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Acute labour pain",
                        "html": "Acute labour pain"
                    }
                ],
                "specificity": {
                    "routes": [
                        "Initially lumbar epidural"
                    ],
                    "textContent": "Initially by lumbar epidural",
                    "html": "Initially by lumbar epidural"
                },
                "adult": [
                    {
                        "textContent": "15&#8211;25 mg every 15 minutes as required, dose administered using a 2.5 mg/mL (0.25%) solution, alternatively (by continuous epidural infusion) 5&#8211;12.5 mg/hour, dose administered using a 1.25 mg/mL (0.125%) solution.",
                        "html": "<p>15&#8211;25&#8239;mg every 15&#8239;minutes as required, dose administered using a 2.5&#8239;mg/mL (0.25%) solution, alternatively (by continuous epidural infusion) 5&#8211;12.5&#8239;mg/hour, dose administered using a 1.25&#8239;mg/mL (0.125%) solution.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Surgical anaesthesia, peripheral nerve block",
                        "html": "Surgical anaesthesia, peripheral nerve block"
                    }
                ],
                "specificity": {
                    "routes": [
                        "regional administration"
                    ],
                    "textContent": "By regional administration",
                    "html": "By regional administration"
                },
                "adult": [
                    {
                        "textContent": "2.5&#8211;150 mg, dose administered using a 2.5 mg/mL (0.25%) or 5 mg/mL (0.5%) solution.",
                        "html": "<p>2.5&#8211;150&#8239;mg, dose administered using a 2.5&#8239;mg/mL (0.25%) or 5&#8239;mg/mL (0.5%) solution.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Surgical anaesthesia, peribulbular nerve block",
                        "html": "Surgical anaesthesia, peribulbular nerve block"
                    }
                ],
                "specificity": {
                    "routes": [
                        "regional administration"
                    ],
                    "textContent": "By regional administration",
                    "html": "By regional administration"
                },
                "adult": [
                    {
                        "textContent": "37.5&#8211;112.5 mg, dose administered using a 7.5 mg/mL (0.75%) solution.",
                        "html": "<p>37.5&#8211;112.5&#8239;mg, dose administered using a 7.5&#8239;mg/mL (0.75%) solution.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Surgical anaesthesia for caesarean section",
                        "html": "Surgical anaesthesia for caesarean section"
                    }
                ],
                "specificity": {
                    "routes": [
                        "lumbar epidural"
                    ],
                    "textContent": "By lumbar epidural",
                    "html": "By lumbar epidural"
                },
                "adult": [
                    {
                        "textContent": "75&#8211;150 mg, to be given over 15 &#8211;20 minutes, dose administered using a 5 mg/mL (0.5%) solution.",
                        "html": "<p>75&#8211;150&#8239;mg, to be given over 15 &#8211;20 minutes, dose administered using a 5&#8239;mg/mL (0.5%) solution.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Surgical anaesthesia",
                        "html": "Surgical anaesthesia"
                    }
                ],
                "specificity": {
                    "routes": [
                        "local infiltration"
                    ],
                    "textContent": "By local infiltration",
                    "html": "By local infiltration"
                },
                "adult": [
                    {
                        "textContent": "50&#8211;150 mg, to be given over 5 minutes, dose administered using a 5 mg/mL (0.5%) or 7.5 mg/mL (0.75%) solution.",
                        "html": "<p>50&#8211;150&#8239;mg, to be given over 5 minutes, dose administered using a 5&#8239;mg/mL (0.5%) or 7.5&#8239;mg/mL (0.75%) solution.</p>"
                    },
                    {
                        "textContent": "15 mg, dose administered using a 5 mg/mL (0.5%) solution.",
                        "html": "<p>15&#8239;mg, dose administered using a 5&#8239;mg/mL (0.5%) solution.</p>"
                    },
                    {
                        "textContent": "2.5&#8211;150 mg, dose administered using a 2.5 mg/mL (0.25%) solution.",
                        "html": "<p>2.5&#8211;150&#8239;mg, dose administered using a 2.5&#8239;mg/mL (0.25%) solution.</p>"
                    }
                ]
            }
        ],
        "extremesOfBodyWeight": [
            {
                "type": "extremesOfBodyWeight",
                "title": "Doses at extremes of body-weight",
                "textContent": "To avoid excessive dosage in obese patients, dose may need to be calculated on the basis of ideal body- weight.",
                "html": "<p>To avoid excessive dosage in obese patients, dose may need to be calculated on the basis of ideal body- weight.</p>"
            }
        ]
    },
    "importantSafetyInformation": {
        "importantSafetyInformation": [
            {
                "type": "importantSafetyInformation",
                "textContent": "The licensed doses stated may not be appropriate in some settings and expert advice should be sought.\n\nShould only be administered by, or under the direct supervision of, personnel experienced in their use, with adequate training in anaesthesia and airway management, and should not be administered parenterally unless adequate resuscitation equipment is available.",
                "html": "<p>The licensed doses stated may not be appropriate in some settings and expert advice should be sought.</p><p>Should only be administered by, or under the direct supervision of, personnel experienced in their use, with adequate training in anaesthesia and airway management, and should not be administered parenterally unless adequate resuscitation equipment is available.</p>"
            }
        ]
    },
    "contraindications": {
        "contraindications": [
            {
                "type": "contraindications",
                "textContent": "Application to the middle ear (can cause ototoxicity)",
                "html": "Application to the middle ear (can cause ototoxicity)"
            },
            {
                "type": "contraindications",
                "textContent": "avoid injection into infected tissues",
                "html": "avoid injection into infected tissues"
            },
            {
                "type": "contraindications",
                "textContent": "avoid injection into inflamed tissues",
                "html": "avoid injection into inflamed tissues"
            },
            {
                "type": "contraindications",
                "textContent": "complete heart block",
                "html": "complete heart block"
            },
            {
                "type": "contraindications",
                "textContent": "preparations containing preservatives should not be used for caudal, epidural, or spinal block, or for intravenous regional anaesthesia (Bier&#8217;s block)",
                "html": "preparations containing preservatives should not be used for caudal, epidural, or spinal block, or for intravenous regional anaesthesia (Bier&#8217;s block)"
            },
            {
                "type": "contraindications",
                "textContent": "should not be applied to damaged skin",
                "html": "should not be applied to damaged skin"
            }
        ],
        "importantAdvice": [
            {
                "type": "importantAdvice",
                "title": "Injection site",
                "textContent": "Local anaesthetics should not be injected into inflamed or infected tissues nor should they be applied to damaged skin. Increased absorption into the blood increases the possibility of systemic side-effects, and the local anaesthetic effect may also be reduced by altered local pH.",
                "html": "<p>Local anaesthetics should not be injected into inflamed or infected tissues nor should they be applied to damaged skin. Increased absorption into the blood increases the possibility of systemic side-effects, and the local anaesthetic effect may also be reduced by altered local pH.</p>"
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Cardiovascular disease",
                "html": "Cardiovascular disease"
            },
            {
                "type": "cautions",
                "textContent": "debilitated patients (consider dose reduction)",
                "html": "debilitated patients (consider dose reduction)"
            },
            {
                "type": "cautions",
                "textContent": "elderly (consider dose reduction)",
                "html": "elderly (consider dose reduction)"
            },
            {
                "type": "cautions",
                "textContent": "epilepsy",
                "html": "epilepsy"
            },
            {
                "type": "cautions",
                "textContent": "hypovolaemia",
                "html": "hypovolaemia"
            },
            {
                "type": "cautions",
                "textContent": "impaired cardiac conduction",
                "html": "impaired cardiac conduction"
            },
            {
                "type": "cautions",
                "textContent": "impaired respiratory function",
                "html": "impaired respiratory function"
            },
            {
                "type": "cautions",
                "textContent": "myasthenia gravis",
                "html": "myasthenia gravis"
            },
            {
                "type": "cautions",
                "textContent": "shock",
                "html": "shock"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (levobupivacaine).",
                "html": "<p>Appendix 1 (levobupivacaine).</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Anaemia",
                        "html": "Anaemia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "arrhythmias",
                        "html": "arrhythmias",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "blurred vision",
                        "html": "blurred vision",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "cardiac arrest",
                        "html": "cardiac arrest",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "convulsions",
                        "html": "convulsions",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "dizziness",
                        "html": "dizziness",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "drowsiness",
                        "html": "drowsiness",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "feeling of inebriation",
                        "html": "feeling of inebriation",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "headache",
                        "html": "headache",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "lightheadedness",
                        "html": "lightheadedness",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "muscle twitching",
                        "html": "muscle twitching",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "myocardial depression (resulting in hypotension and bradycardia)",
                        "html": "myocardial depression (resulting in hypotension and bradycardia)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "nausea",
                        "html": "nausea",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "numbness of the tongue and perioral region",
                        "html": "numbness of the tongue and perioral region",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "paraesthesia (including sensations of hot and cold)",
                        "html": "paraesthesia (including sensations of hot and cold)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "peripheral vasodilatation (resulting in hypotension and bradycardia)",
                        "html": "peripheral vasodilatation (resulting in hypotension and bradycardia)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "pyrexia",
                        "html": "pyrexia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "restlessness",
                        "html": "restlessness",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "sweating",
                        "html": "sweating",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "tinnitus",
                        "html": "tinnitus",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "transient excitation (followed by depression with drowsiness, respiratory failure, unconsciousness, and coma)",
                        "html": "transient excitation (followed by depression with drowsiness, respiratory failure, unconsciousness, and coma)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "tremors",
                        "html": "tremors",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "vomiting",
                        "html": "vomiting",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        },
        "advice": [
            {
                "type": "advice",
                "title": "Toxic effects",
                "textContent": "Toxic effects after administration of local anaesthetics are a result of excessively high plasma concentrations; severe toxicity usually results from inadvertent intravascular injection or too rapid injection.\n\nFollowing most regional anaesthetic procedures, maximum arterial plasma concentration of anaesthetic develops within about 10 to 25 minutes, so careful surveillance for toxic effects is necessary during the first 30 minutes after injection.\n\nThe systemic toxicity of local anaesthetics mainly involves the central nervous and cardiovascular systems.",
                "html": "<p>Toxic effects after administration of local anaesthetics are a result of excessively high plasma concentrations; severe toxicity usually results from inadvertent intravascular injection or too rapid injection.</p><p>Following most regional anaesthetic procedures, maximum arterial plasma concentration of anaesthetic develops within about 10 to 25 minutes, so careful surveillance for toxic effects is necessary during the first 30 minutes after injection.</p><p>The systemic toxicity of local anaesthetics mainly involves the central nervous and cardiovascular systems.</p>"
            }
        ]
    },
    "allergyAndCrossSensitivity": {
        "crossSensitivity": [
            {
                "type": "crossSensitivity",
                "title": "Hypersensitivity and cross-sensitivity",
                "textContent": "Hypersensitivity reactions occur mainly with the ester-type local anaesthetics, such as tetracaine and chloroprocaine; reactions are less frequent with the amide types, such as articaine, bupivacaine, levobupivacaine, lidocaine, mepivacaine, prilocaine, and ropivacaine. Cross-sensitivity reactions may be avoided by using the alternative chemical type.",
                "html": "<p>Hypersensitivity reactions occur mainly with the ester-type local anaesthetics, such as tetracaine and chloroprocaine; reactions are less frequent with the amide types, such as articaine, bupivacaine, levobupivacaine, lidocaine, mepivacaine, prilocaine, and ropivacaine. Cross-sensitivity reactions may be avoided by using the alternative chemical type.</p>"
            }
        ]
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Large doses during delivery can cause neonatal respiratory depression, hypotonia, and bradycardia after epidural block.\n\nAvoid if possible in the first trimester&#8212;toxicity in animal studies.\n\nMay cause fetal distress syndrome.\n\nDo not use for paracervical block in obstetrics.\n\nDo not use 7.5 mg/mL strength in obstetrics.",
                "html": "<p>Large doses during delivery can cause neonatal respiratory depression, hypotonia, and bradycardia after epidural block.</p><p>Avoid if possible in the first trimester&#8212;toxicity in <i>animal</i> studies.</p><p>May cause fetal distress syndrome.</p><p>Do not use for paracervical block in obstetrics.</p><p>Do not use 7.5&#8239;mg/mL strength in obstetrics.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Amount too small to be harmful.",
                "html": "<p>Amount too small to be harmful.</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Use with caution.",
                "html": "<p>Use with caution.</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "textContent": "For 1.25 mg/mL concentration dilute standard solutions with sodium chloride 0.9%.",
                "html": "<p>For 1.25&#8239;mg/mL concentration dilute standard solutions with sodium chloride 0.9%.</p>"
            }
        ]
    },
    "prescribingAndDispensingInformation": {
        "prescribingAndDispensingInformation": [
            {
                "type": "prescribingAndDispensingInformation",
                "textContent": "Levobupivacaine is an isomer of bupivacaine.",
                "html": "<p>Levobupivacaine is an isomer of bupivacaine.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP75739",
                "label": "Solution for injection",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75750",
                "label": "Infusion",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78353",
                "label": "Local anaesthesia",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_906",
                "label": "Levobupivacaine",
                "type": "interaction"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP75739",
                "label": "Solution for injection",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75750",
                "label": "Infusion",
                "type": "medicinalForm"
            }
        ]
    }
}